Core Laboratories (CLB) Invested Capital (2022 - 2026)

Core Laboratories has reported Invested Capital for 5 years, with the latest figure at $275.1 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 8.35% year-over-year to $275.1 million; the trailing twelve-month figure through Mar 2026 stood at $275.1 million (up 8.35% YoY), and the FY2025 full-year result was $266.0 million, up 5.42% from the prior year.
• Invested Capital for Q1 2026 stood at $275.1 million, up from $266.0 million in the prior quarter.
• The five-year high for Invested Capital was $275.1 million in Q1 2026, with the low at $173.8 million in Q2 2022.
• Historically, Invested Capital has averaged $233.7 million across 5 years, with a median of $241.6 million in 2024.
• Annual changes were most pronounced in 2023 — Invested Capital gained 26.38% — and 2025, when it advanced 5.42%.
• Core Laboratories' Invested Capital stood at $183.5 million in 2022, then increased by 22.26% to $224.4 million in 2023, then grew by 12.45% to $252.3 million in 2024, then rose by 5.42% to $266.0 million in 2025, then increased by 3.44% to $275.1 million in 2026.
• The last three Invested Capital figures came in at $275.1 million (Q1 2026), $266.0 million (Q4 2025), and $271.3 million (Q3 2025), per Business Quant data.